As drug development becomes increasingly competitive, many sponsors are turning to comparative trials to demonstrate a study drug’s enhanced efficacy and tolerability over the best performing, commercially available alternative.

Yet the potential on offer can quickly be lost if comparator sourcing is not given the care, attention and expertise it warrants.

With recently published data revealing that 60% of sponsors surveyed identified comparator sourcing as a key stumbling block for losing time and money in clinical trial supply, and with the number of clinical trials comparing two active drugs rising, there’s never been a better time to get to grips with how to design a best practice approach to managing supply for comparative trials.

Download our Guide to discover a few tips to get started.